Delivery Order SPE2DB22D2206-SPE2DB24FHX52

Award Date 6/25/24
Potential Completion Date 6/26/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML. The $2,439.79 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 3, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML. The $3,156.00 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), which is a defense agency. The contract has a completion date of May 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,052.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $3,156.00 and a period of performance through June 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $3,156.00 firm fixed price delivery order for the pharmaceutical product "MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML". The contract was awarded on June 14, 2024, with a completion date of June 17, 2024, by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order with a Firm Fixed Price of $1,052.00 and an ultimate completion date of May 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides for the delivery of the pharmaceutical product Mounjaro 5 mg/0.5 ml pen 0.5 ml to the U.S. government. The contract, valued at $11,337.24, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The $14,906.00 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on June 24, 2024, with a completion date of June 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The $5,260.00 fixed-price delivery order was awarded on June 5, 2024 by the Defense Logistics Agency (DLA), with a scheduled completion date of June 6, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the pharmaceutical product MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The $2,367.00 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, with an ultimate completion date of June 17, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHX52
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML. The $1,052.00 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 26, 2024.

Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific award is not designated as a set-aside contract. Amerisourcebergen has significant experience and a strong position in the federal pharmaceutical supply market, serving numerous government agencies including the Department of Justice.

Generated 9/24/24, 9:28 AM